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Abstract
Adolescent obesity is a serious health problem associated with many comorbidities. Obesity-related alterations in circadian
rhythm have been described for nocturnal blood pressure and for metabolic functions. We believe renal circadian rhythm is also
disrupted in obesity, though this has not yet been investigated. This study aimed to examine renal circadian rhythm in obese
adolescents before and after weight loss.
In 34 obese adolescents (median age 15.7 years) participating in a residential weight loss program, renal function profiles and
blood samples were collected at baseline, after 7 months, and again after 12 months of therapy. The program consisted of dietary
restriction, increased physical activity, and psychological support. The program led to a median weight loss of 24 kg and a
reduction in blood pressure. Initially, lower diurnal free water clearance (− 1.08 (− 1.40–− 0.79) mL/min) was noticed compared
with nocturnal values (0.75 (− 0.89–− 0.64) mL/min). After weight loss, normalization of this inverse rhythm was observed (day
− 1.24 (− 1.44–1.05) mL/min and night − 0.98 (− 1.09–− 0.83) mL/min). A clear circadian rhythm in diuresis rate and in renal
clearance of creatinine, solutes, sodium, and potassium was seen at all time points. Furthermore, we observed a significant
increase in sodium clearance. Before weight loss, daytime sodium clearance was 0.72 mL/min (0.59–0.77) and nighttime
clearance was 0.46 mL/min (0.41–0.51). After weight loss, daytime clearance increased to 0.99 mL/min (0.85–1.17) and
nighttime clearance increased to 0.78 mL/min (0.64–0.93).
Conclusion: In obese adolescents, lower diurnal free water clearance was observed compared with nocturnal values. Weight
loss led to a normalization of this inverse rhythm, suggesting a recovery of the anti-diuretic hormone activity. Both before and
after weight loss, clear circadian rhythm of diuresis rate and renal clearance of creatinine, solutes, sodium, and potassium was
observed.
What is Known:
• Obesity-related alterations in circadian rhythm have been described for nocturnal blood pressure and for metabolic functions. We believe renal
circadian rhythm is disrupted in obesity, though this has not been investigated yet.
What is New:
• In obese adolescents, an inverse circadian rhythm of free water clearance was observed, with higher nighttime free water clearance compared with
daytime values. Weight loss led to a normalization of this inverse rhythm, suggesting a recovery of the anti-diuretic hormone activity.
• Circadian rhythm in diuresis rate and in the renal clearance of creatinine, solutes, sodium, and potassium was preserved in obese adolescents and did
not change after weight loss.
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Abbreviations
ACE Angiotensin-converting enzyme
ADH Anti-diuretic hormone
AGT Angiotensinogen
AngII Angiotensin II
BMI Body mass index
BP Blood pressure
BSA Body surface area
DM Diabetes mellitus
eGFR Estimated glomerular filtration rate
FWC Free water clearance
GFR Glomerular filtration rate
RAAS Renin-angiotensin-aldosterone system
RFP Renal function profile
RPF Renal plasma flow
Introduction
Adolescent obesity is a serious public health problem world-
wide. During the last few decades, the prevalence of child-
hood and adolescent obesity has increased at an alarming rate,
not only in the Western world but also in low- and middle-
income countries (WHO) [35]. Up to 11–15% of Belgian chil-
dren and adolescents are overweight and 3–5% are reportedly
obese. Children with obesity have an increased risk of becom-
ing obese adults [4, 11, 18, 20, 31] and, developing chronic
conditions, such as cardiovascular disease, diabetes mellitus
(DM), hypertension, and kidney disease [19, 28].
We hypothesized that adolescent obesity is associated with
a disruption of renal circadian rhythm. Like many other bio-
logical processes, renal functions exhibit clear circadian vari-
ations. Urine production and voiding tend to predominate dur-
ing the awakening phase, whereas increased urine storage and
reduced micturition frequency predominate during the
sleeping phase [25]. This circadian rhythm is believed to be
driven by a self-sustained central system, located in the supra-
chiasmatic nucleus of the hypothalamus, communicating with
peripheral systems in nearly every cell type [10, 25]. This
system influences renal blood flow and circulating hormones
affecting urine production and storage, sympathetic/
parasympathetic tone, blood pressure (BP), and thus, glomer-
ular filtration rate (GFR), and water and solute handling [9].
Disturbances in proper voiding rhythms are typically pres-
ent in children with nocturnal enuresis and elderly individuals
with nocturia [10]. Renal circadian rhythm in obesity has not
yet been investigated. Previous studies, however, have ob-
served obesity-related alterations in the circadian rhythm of
other biological functions. Macumber et al. [21] demonstrated
that obesity is associated with a relative decrease in nocturnal
BP dipping in children. Pagano et al. [26] discussed the de-
ranged circadian rhythm of metabolic functions and glucose
homeostasis in obese adults.
Subsequently, obesity-related kidney dysfunction has been
examined in adults. This dysfunction is believed to be indirect-
ly mediated by comorbid conditions, such as DM and hyper-
tension, and directly mediated by physical compression of the
kidneys by visceral adiposity, inflammation, endothelial dys-
function [33], hyperinsulinemia [27], and a deranged endocrine
activity of the visceral adipose tissue. Hyperinsulinemia leads
to increased sodium and potassium reabsorption, independent-
ly of GFR and plasma aldosterone [22, 26]. Deranged endo-
crine activity may affect kidney function through three mecha-
nisms: an overactive renin-angiotensin-aldosterone system
(RAAS) [3, 6, 28, 30], a dysregulated natriuretic peptides sys-
tem [29], or an overactive sympathetic nervous system [7].
These direct and indirect mechanisms contribute to impaired
pressure natriuresis, increased renal tubular sodium reabsorp-
tion, and blood volume expansion [14, 19]. As a result, a com-
pensatory increase in renal plasma flow (RPF), glomerular
pressure, and hyperfiltration sets in tomaintain sodium balance.
This compensation spurs the development of glomerular hy-
pertension, increased glomerular permeability, and proteinuria,
and ultimately leads to glomerulomegaly and focal segmental
glomerulosclerosis [5, 16, 29, 32]. Several studies showed that
weight loss in obese patients can improve glomerular hemody-
namics and, thus, counteract the development of obesity-
related renal insufficiency [2, 5]. We propose that these afore-
mentioned mechanisms of kidney disease contribute to a de-
rangement of the renal circadian rhythm as well.
The objective of this prospective study was to examine
renal circadian rhythm in obese adolescents before and after
weight loss.
Materials and methods
Patient selection
This prospective interventional study was performed at the
medical pediatric rehabilitation center “Zeepreventorium^,
De Haan, between July 2016 and June 2017. Obese ado-
lescents aged 10 to 19-year-olds were recruited at the be-
ginning of a 12-month residential obesity treatment pro-
gram. Exclusion criteria were comorbidities (kidney failure,
heart failure, liver failure, DM, and diabetes insipidus),
pregnancy, and intake of medication with a potential effect
on urine output (diuretics, desmopressin, ACE-inhibitors,
AngII receptor antagonists, non-steroidal anti-inflammatory
drugs, corticosteroids, lithium, and selective serotonin reup-
take inhibitors). After data collection, 19 patients were ex-
cluded from analysis due to early discharge, incomplete
urine sampling, incorrect urine sampling, impossibility of
urine sampling due to a tibial fracture, or start of an
ACE-inhibitor (Fig. 1).
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Participants followed a multidisciplinary program, which
consisted of moderate dietary restriction, psychological sup-
port, and regular physical activity. The diet consisted of 1600–
1900 kcal/day, 200–250 g of carbohydrates, 25–35 g of fats,
75–90 g of proteins, and a sodium and potassium content of
2.5–4 g daily. Adolescents were encouraged to drinking at
least 2 glasses of water (or milk during breakfast) with their
meals and carry a water bottle at all times. This water replaced
the soda or juice that the adolescents were used to drink before
enrollment. Physical activity consisted of 2 h of supervised
play and lifestyle activities daily, 100 min of physical educa-
tion courses per week at school, and 150 min of supervised
training sessions every week. Qualified physiotherapists su-
pervised the participants during all training sessions [1].
Data collection
Data was collected at the following 3 time points: at the onset
of the residential program in July 2016, mid-term after
7 months of treatment and at its completion after 12 months
in June 2017. All patients completed a renal function profile
(RFP) and a morning blood sample. BP, body weight, and
height were measured. Standardized measurements were ob-
tained at all time points: identical daily routines with
standardized meals and fluid intake, similar sports activities,
and comparable day-night rhythm.
Anthropometry and comorbidities
Anthropometric measurements were performed after break-
fast, with the subjects wearing light school uniform clothing,
without footwear. Bodyweight was measured on a digital
scale with a precision of 0.1 kg and height was measured to
the nearest 0.01 m using a wall-mounted stadiometer. Body
mass index (BMI) was calculated as weight/heigth2 (kg/m2).
BMI z-score was calculated as BMI adjusted to weight, height,
and age. Overweight and obesity were defined as a BMI equal
to or above the age- and gender-specific 85th and 97th per-
centile respectively according to regional charts in adolescents
younger than 16 years. In adolescents older than 16 years,
overweight and obesity were defined as BMI ≥ 30 and ≥ 35
respectively.
BP was measured three times in the seated position by an
automated electronic sphygmomanometer (GE Healthcare,
Carescape V100). Hypertension was defined as a mean sys-
tolic and/or diastolic BP equal to or above the age-, gender-,
and height-specific 95th percentile [23]. Presence of insulin
19 excluded from analysis:
- Early discharge (n = 12)
- Incomplete urine sampling (n = 4)
- Incorrect urine sampling (n = 1)
- Impossibility of urine sampling 
due to bia fracture (n = 1)
- Start ACE-inhibitor (n = 1)
34 eligible for analysis
53 signed informed consent 
71 matching inclusion criteria 
18 excluded due to comorbidies 
Inclusion criteria:
- Age 10 - 19 years
- < 16 years: BMI  ≥97th age- and 
gender-specific percenle 
- > 16 years : BMI ≥ 35
Fig. 1 Flowchart overviewing
patient selection for analysis
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resistance was extracted from the medical files of the
participants.
RFP and blood sampling
A RFP is a 24 h-urine collection in which urine samples are
collected at fixed time points every 3 h, starting 3 h after the
first-morning void. Daytime samples were taken at 9 am (1),
12 am (2), 15 pm (3), 18 pm (4), and 21 pm (5). The nighttime
samples were taken at 0 am (6), 3 am (7), and 6 am (8). The
volume of each sample, and of each micturition in between,
was noted to calculate the 24 h, daytime and nighttime urine
volume and diuresis rate. After an overnight fast, a sober se-
rum sample was taken.
Biochemical analyses
Sodium, potassium, osmolality, and creatinine were measured
in the blood sample and for each of the 8 urine samples. The
renal clearance of creatinine, solutes, sodium, and potassium
(Usubst × Uflow/Psubst), free water clearance (FWC) (urine
flow-solute clearance), fractional excretion of sodium, and
potassium (Usubst × Pcreat/Ucreat × Psubst) were calculated.
eGFR was calculated and corrected for the body surface area
(BSA) (creatinine clearance × 1.73/BSA).
Statistical analysis
Statistical analysis was performed using SPSS®, version 25.
The median, interquartile range (IQR), and frequency were
recorded as descriptive parameters. The Shapiro-Wilk test
was used to identify the normal distribution of the variables.
The McNemar test was used to compare two paired categor-
ical variables. The continuous variables were analyzed using
the non-parametricWilcoxonmatched-pairs signed-ranks test.
Statistical significance was assessed using two-tailed tests and
determined by p < 0.05. To identify independent predictors for
altered circadian rhythm, a multivariate Cox regression anal-
ysis with calculation of the hazard ratio was performed.
The study was approved by the Ghent University Hospital
review board (EC 2015/1438). The Declaration of Helsinki
was followed and conducted in accordance with the legal regu-
lations in Belgium.Written informed consent was obtained from
both the parents and all individual participants included in the
study.
Results
Patient characteristics and comorbidities
A total of 34 patients were eligible for analysis. Median age at
baseline was 15.7 (14.1–16.7) years, and 73.5% of participants
were female. One year of treatment led to a median weight loss
of 24.0 (17.9–33.5) kg or 21.9 (18.7–28.3) %. The median BMI
z-score at baseline was calculated at 2.42 (2.23–2.73) and de-
creased significantly (p < 0.001) after treatment (1.56 (1.28–
1.92)). Each adolescent participating in the study showed a
weight loss (minimum weight loss of 11.9 kg). Weight loss
was more pronounced in the male group, leading to a median
male weight loss of 41.9 kg compared with females (21.4 kg).
After treatment, 6 adolescents had a normal BMI, 12 were over-
weight, and 16 remained obese. A significant decrease in BPwas
observed after both 7 and 12months of weight loss. At the end of
the treatment program, the systolic BP decreased significantly
(p < 0.001) to a median of 114.5 (106.5–120.55) mmHg and
the diastolic BP decreased (p = 0.043) to a median of 67.5 (62–
72.25) mmHg. Initially, 27 (79.4%) patients were assessed as
hypertensive. After 12 months of weight loss, only 4 (11.8%)
patients were classified as hypertensive. Before weight loss, 28
(82.4%) patients had insulin resistance, which diminished signif-
icantly (p < 0.001) to 6 (17.6%) patients at the end of the program
(Table 1 and Fig. 2).
Renal function profile
Diuresis rate
Before and after 12 months of weight loss, the diuresis rate
was significantly lower during the nighttime compared with
daytime measurements (p = 0.013 and p = 0.002, respective-
ly). Nevertheless, this circadian rhythm appeared more pro-
nounced after weight loss. A significant increase in diuresis
rate was reported after 7 and 12 months of treatment
(p < 0.001 and p < 0.001, respectively) (Table 2 and Fig. 3).
Creatinine clearance
A significant decrease in nighttime creatinine clearance com-
pared with daytime clearance was demonstrated before
(p < 0.001) and after (p = 0.043) weight loss. Creatinine clear-
ance was not statistically different between baseline measure-
ment and follow-up time points (p = 0.4 and p = 0.071, respec-
tively) (Table 2 and Fig. 3). We calculated the eGFR as creat-
inine clearance per 1.73 m2 and noted a significant increase
(p = 0.007) to a median eGFR after weight loss of 137.57
(123.50–155.73) mL/min.
Free water clearance
Before and after 7 months of treatment, nocturnal FWC was
significantly higher than daytime values (p < 0.001 and
p < 0.001, respectively). After 12 months of weight loss,
nighttime FWC did not differ from daytime levels (p =
0.091). After 7 and 12 months of treatment, no significant
change in FWC was observed (p = 0.082 and p = 0.321,
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respectively). However, we noted a trend toward lower FWC
after weight loss (Table 2 and Fig. 4). When calculating the
FWC per 1.73 m2, we noted no significant change (p = 0.062)
from baseline (− 0.73 (− 1.05–− 0.61) to after 12 months of
treatment (− 1.04 (− 1.30–− 0.70). A multivariate logistic re-
gression analysis was done to evaluate gender, obesity, and
hypertension after treatment as potential risk factors for a
disrupted circadian rhythm of FWC. However, none of these
factors was determined to be potential risk factors (gender
(p = 0.41), hypertension (p = 0.95), obesity after treatment
(p = 0.84)).
Solute clearance
Compared with daytime values, a significant decrease in sol-
ute clearance during the night was reported at all time points
(p < 0.001, p < 0.001, and p < 0.001, respectively). A signifi-
cant increase in solute clearance was seen after 7 (p < 0.001)
and 12 months of weight loss (p < 0.001) (Table 2 and Fig. 4).
Sodium clearance A significant circadian rhythm with lower
nighttime sodium clearance values than daytime measure-
ments was observed at all time points (p < 0.001, p = 0.013,
p = 0.029, respectively). U4 shows a clear dip in sodium clear-
ance before and after treatment. For sodium clearance, a sig-
nificant increase was noted after 7 and 12 months of weight
loss (p = 0.03 and p < 0.001, respectively) (Table 2 and
Fig. 4). Fractional excretion of sodium exhibited a similar
pattern with a significant increase from 0.44 (0.34–0.51) %
to 0.62 (0.48–0.73) % (p < 0.001) after treatment.
Potassium clearance Nocturnal potassium clearance was sig-
nificantly lower than daytime measurement at all points
(p < 0.001, p < 0.001, and p < 0.001, respectively). A signifi-
cant increase in potassium clearance was reported after 7
(p < 0.001) and 12 months (p < 0.001) (Table 2 and Fig. 4).
A significant increase in baseline fractional excretion of po-
tassium (5.79 (4.96–6.55) %) was observed after 12 months
(7.69 (6.43–9.82) %) (p < 0.001).
Discussion
The objective of this prospective study was to examine renal
circadian rhythm in obese adolescents before and after weight
loss.
Table 1 Patient characteristics
Baseline After 7 months After 12 months
p value*1 p value*2
Height (m) 1.69 (1.62–1.77) 1.70 (1.63–1.78) / 1.70 (1.64–1. 79) /
Weight (kg) 108.4 (93.5–130.4) 85.4 (77.3–108.4) < 0.001 78.3 (72.8–100.9) < 0.001
BMI (kg/m2) 37.2 (33.4–43.8) 29.6 (27.4–34.3) < 0.001 28.04 (25.51–31.23) < 0.001
BMI z-score 2.42 (2.23–2.73) 1.81 (1.43–2.19) < 0.001 1.56 (1.28–1.92) < 0.001
Systolic BP (mmHg) 134 (127.75–143) 120 (112.75–125.25) < 0.001 114.5 (106.5–120.25) < 0.001
Diastolic BP (mmHg) 72 (64.75–79) 61.5 (58–68.25) 0.002 67.5 (62–72.25) 0.043
Hypertension 27 (79.4%) 9 (26.5%) < 0.001 4 (11.8%) < 0.001
Insulin resistance 28 (82.4%) / / 6 (17.4%) < 0.001
*Differences between the groups before and after treatment were calculated with theWilcoxon matched-pairs signed-ranks test and McNemar test. Data
are reported as median (interquartile range); P values < 0.05 were considered statistically significant and are in italics
1 Comparing measurements at baseline and after 7 months
2 Comparing measurements at baseline and after 12 months
Systolic Diastolic
Fig. 2 Differences in systolic and diastolic blood pressure before and
after 12 months of weight loss-therapy
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In the present study, an inverse circadian rhythm of FWC
was observed, both before and after 7 months of treatment,
with lower daytime compared with nighttime values. This
finding is inconsistent with the theory that in healthy children
Table 2 Interpretation of RFP
Baseline After 7 months After 12 months
p value*1 p value*2
Diuresis rate (mL/min) Day 0.78 (0.67–1.00) 0.87 (0.70–1.15) 0.009 1.38 (0.94–1.70) < 0.001
Night 0.57 (0.46–0.81) 0.74 (0.65–0.97) < 0.001 0.87 (0.75–1.05) < 0.001
24 h 0.78 (0.69–0.86) 0.80 (0.71–1.28) < 0.001 1.21 (0.89–1.49) < 0.001
Creatinine clearance (mL/min) Day 165.15 (132.27–191.75) 167.85 (147.80–181.47) 0.3 158.03 (144.49–179.01) 0.993
Night 133.61 (118.76–158.95) 135.15 (121.76–146.80) 0.5 147.67 (132.40–163.58) 0.071
24 h 149.84 (135.12–182.12) 156.78 (141.24–170.67) 0.4 160.86 (142.15–173.67) 0.437
FWC (mL/min) Day − 1.08 (− 1.40–− 0.79) − 1.33 (− 1.59–− 1.02) 0.2 − 1.24 (− 1.44–− 1.05) 0.561
Night − 0.75 (− 0.89–− 0.64) − 0.90 (− 1.10–− 0.72) 0.059 − 0.98 (− 1.09–− 0.83) 0.055
24 h − 0.95 (− 1.14–− 0.78) − 1.09 (− 1.45–− 0.92) 0.082 − 1.09 (− 1.42–− 0.96) 0.321
Solute clearance (mL/min) Day 1.97 (1.65–2.30) 2.48 (2.18–2.69) 0.004 2.64 (2.19–2.97) 0.001
Night 1.36 (1.24–1.60) 1.79 (1.59–1.94) < 0.001 1.87 (1.73–2.13) < 0.001
24 h 1.79 (1.60–1.97) 2.27 (2.09–2.46) < 0.001 2.39 (2.12–2.58) < 0.001
Sodium clearance (mL/min) Day 0.72 (0.59–0.77) 0.75 (0.68–0.98) 0.1 0.99 (0.85–1.17) < 0.001
Night 0.46 (0.41–0.51) 0.62 (0.46–0.79) 0.003 0.78 (0.64–0.93) < 0.001
24 h 0.65 (0.55–0.70) 0.79 (0.65–0.87) 0.03 0.91 (0.85–1.10) < 0.001
Potassium clearance (mL/min) Day 11.83 (10.63–13.31) 15.42 (13.46–19.24) < 0.001 16.80 (13.93–19.11) < 0.001
Night 3.51 (2.98–4.06) 4.41 (3.49–5.89) < 0.001 4.79 (4.37–5.71) 0.002
24 h 9.05 (7.62–9.82) 12.28 (10.15–113.53) < 0.001 12.89 (10.33–15.19) < 0.001
*Data are reported as median (95% confidence interval). Day sample includes the first 5 urine collections, whereas the night sample includes the last 3
urine samples; p values < 0.05 were considered statistically significant and are in italics
1 Comparing measurements at baseline and after 7 months
2 Comparing measurements at baseline and after 12 months
9 am 12 am 3 pm 6 pm 9 pm 12 pm 3 am 6 am 9 am 12 am 3 pm 6 pm 9 pm 12 pm 3 am 6 am
a b
Fig. 3 Change in different parameters at 3 h fixed time points before and
after 12 months of weight loss therapy. a Change in diuresis rate (mL/
min), b change in creatinine clearance (mL/min). Differences between
baseline and after treatment measurement of every time point were
calculated with the Wilcoxon matched-pairs signed-ranks test. p values
< 0.05 were considered statistically significant and are mentioned with an
asterisk (*). The end of the whiskers represents the 5th and 95th percentile
of the measurements
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and adults, increased secretion of ADH is expected during the
night. The elevated excretion of ADH comes along with a
reduction in FWC during nighttime compared with daytime.
This mechanism is essential, as it leads to the production of
more concentrated urine during the night and thus, a reduction
in micturition frequency [17]. The disrupted day-night rhythm
of FWC in our population may be provoked by a reversed
ADH activity with lower ADH levels during the night, leading
to a higher nocturnal FWC during the night. Another possible
explanation is the nocturnal mobilization of obesity-related
peripheral edema as obesity may be a cause of lower extremity
lymphedema and venous insufficiency. As a result, interstitial
fluid accumulates in the lower extremities while standing dur-
ing daytime and is reabsorbed into the circulation when laying
down during sleep. This shift represents a surplus of free water
that the kidneys need to remove trough a stimulated natriuretic
peptides system and suppressed ADH [8, 12, 13]. After
12 months of weight loss, no significant difference in day
9 am 12 am 3 pm 6 pm 9 pm 12 pm 3 am 6 am
9 am 12 am 3 pm 6 pm 9 pm 12 pm 3 am 6 am 9 am 12 am 3 pm 6 pm 9 pm 12 pm 3 am 6 am
9 am 12 am 3 pm 6 pm 9 pm 12 pm 3 am 6 am
a b
c d
Fig. 4 Change in water handling and solutes clearance at 3 h fixed time
points before and after 12 months of weight loss therapy. a Solute
clearance (mL/min); b sodium clearance (mL/min); c potassium
clearance (mL/min); d change in free water clearance (mL/min).
Differences between baseline and after treatment measurement of every
time point were calculated with theWilcoxonmatched-pairs signed-ranks
test. p values < 0.05 were considered statistically significant and are men-
tioned with an asterisk (*). The end of the whiskers represents the 5th and
95th percentile of the measurements
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and nighttime FWC was reported, suggesting a normalization
of the circadian rhythm.
Clear circadian rhythms of diuresis rate and of the
renal clearance of creatinine, solutes, sodium, and potas-
sium were observed at baseline and after completion of
the weight loss program. The dip of sodium clearance in
sample U4 can be explained by the daily 2 h of play and
lifestyle activities before U4 sampling. Blunted renal cir-
cadian rhythms in accordance with disrupted daily
rhythms of BP and other metabolic functions in obese
patients were expected, as described in previous studies
[21, 26]. This largely preserved renal circadian rhythm
may be explained by the short duration of obesity in our
adolescent study population, perhaps being too short to
affect the rhythm of renal function. Another possibility is
that our study sample is a variant of the obese population
with preserved renal circadian rhythm. Further research
to investigate these circadian rhythms in the obese pop-
ulation is necessary.
An overall median weight loss of 24 kg did not affect
creatinine clearance and even led to a significant increase in
eGFR. A decrease was expected since Chagnac et al. [5] and
Navarro-Díaz et al. [24] reported a substantial decrease in
renal hyperfiltration after bariatric surgery in obese adults.
The eGFR was calculated as milliliter per minute per
1.73 m2 and showed a significant increase after 12 months
of weight loss. This discrepancy is likely an artifact attribut-
able to the decrease in BSA and not due to a change in renal
size or function. Several possible explanations for the lack of
change in creatinine clearance in this study are plausible.
Firstly, the follow-up period of this study was short and,
47% of adolescents were still obese after 12 months of treat-
ment. As a result, weight loss may not have been sufficient or
prolonged enough to affect changes in renal filtration. Second,
it is possible that the hyperfiltration theory is not correct or not
applicable for obese adolescents.
A decrease in the obesity-related hyperactive RAAS
established by weight loss has been described in previous
studies [6, 15, 34] and was confirmed by our findings. A
significant increase in sodium clearance was observed after
12 months of weight loss, which can be explained by lower
aldosterone concentrations. This increase in sodium clearance
only becomes evident at the end of the treatment program,
suggesting that adequate weight loss is necessary. The ob-
served elevation in potassium clearance after weight loss can-
not necessarily be attributed to diminished activity of the
RAAS. This elevation may be explained by an increased in-
take of potassium since meals were not identical at each test
moment. The significant decrease in both systolic and diastol-
ic BP after weight loss can be explained by a normalization of
the RAAS, as well.
Limitations of this study include the small number of
participants, the short follow-up period and the fact that
plasma renin and aldosterone measurements were not in-
cluded in the study protocol. Moreover, this study is only
generalizable to adolescents without obesity-related co-
morbidities, as these patients were excluded from the
analysis. Another limitation is the inability to isolate
weight loss from a multidisciplinary program including
many lifestyle modifications. Furthermore, it was not
possible to use values that corrected for BSA, because
of its large variability within and between the obese pa-
tients. In addition, the exact water intake by the adoles-
cents was not measured. This could be a confounder, as
increased water consumption after initiation of the pro-
gram can influence the renal function profiles. The GFR
was calculated and not measured through inulin clear-
ance in the 24-h urine sample. In addition, 24-h blood
pressure measurement was not performed. Lastly, due to
practical and ethical limitations of the study, we could
not include a control group of healthy non-obese
adolescents.
Conclusion
In the present study, 34 obese adolescents were moni-
tored during a 12-month weight loss program. This pro-
gram led to a median weight loss of 24 kg, a reduction
in both systolic and diastolic BP, and improvement of
insulin resistance.
Initially, an inverse circadian rhythm of FWC was observed,
with lower daytime compared with nighttime values. This may
be provoked by a deranged ADH activity and the nocturnal
mobilization of obesity-related peripheral edema. After
12 months of weight loss, normalization of this inverse rhythm
was noticed.
Furthermore, this study showed clear circadian
rhythms in diuresis rate and the renal clearance of cre-
atinine, solutes, sodium, and potassium at the beginning
and end of the weight loss program. Possible explana-
tions for this largely preserved renal circadian rhythm
include a short duration of obesity in our adolescent
study population.
A decrease in the obesity-related hyperactive RAAS was
suggested as a result of the significant increase in sodium
clearance that was observed. Future studies with a larger study
population, healthy controls, and a longer follow-up period
must be performed to confirm our findings.
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